Recursion Pharmaceuticals faces a 57% stock drop amid drug setbacks, rising cash burn, and AI discovery doubts.

Concerns about a possible cancer cluster at a Missouri elementary school may soon be under the federal microscope.

Julie is sharing her story with the hopes of helping others. She wants to share stories of hope, inspiration and how to help ...